Kelly Long, M.S., DABT

Kelly Long brings to Inotiv over 20 years of pharmaceutical experience in drug discovery, with an emphasis on in vivo pharmacology and toxicology. Long began her career at Monsanto/Pharmacia/Pfizer in 1998 as an in vivo pharmacologist and also functioned as a pharmacology project team leader. She joined Inotiv’s legacy company, Seventh Wave, in 2010 as a study director and has held roles of increasing responsibility in the Inotiv in-life operation, currently leading a cross-site in vivo team in St. Louis and West Lafayette.

Long acts as a consultant, provides cross-site leadership and strategic direction, and fosters cross-site alignment for pharmacology, toxicology, and other in-life-related issues. She is a member of the American College of Toxicology and the Society of Toxicology.

Back to Team